Stent Market Analysis: Growth Drivers, Trends, and Future Outlook
The Stent market accounted for USD 14.3 Billion in 2024 and is expected to reach USD 23.7 Billion by 2035, growing at a CAGR of around 4.7% between 2025 and 2035.
The Global stent market is expected to post impressive growth over the forecast years, reaching USD 23.7 billion by 2035, up from USD 14.3 billion in 2024. This represents a steady compound annual growth rate (CAGR) of approximately 4.7% from 2025 to 2035. With the increasing prevalence of cardiovascular diseases, chronic illnesses, and an aging population, demand for stents is rising across healthcare systems worldwide. Let's take a closer look at the major trends driving the market and understand the competitive landscape, the latest technological advancements, and the future outlook.
Stent Market Overview
Stents are small yet critical devices that are used to treat a variety of vascular and non-vascular blockages. In the treatment of cardiovascular diseases, urinary tract diseases, and related conditions, stents play a central role. They work by keeping the vessel or organ in question open, thus promoting blood flow or allowing proper drainage to occur, preventing further complications.
The stent market can be segmented mainly into vascular, including coronary and peripheral stents, and non-vascular types, which include gastrointestinal, pulmonary, and urological stents. Vascular stents include coronary stents, which are applied in coronary artery disease, and peripheral stents for diseases such as those of the iliac, femoral, renal, and carotid arteries.
Key Market Drivers
Several factors are driving the growth of the global stent market:
Increasing Prevalence of Cardiovascular and Chronic Diseases: CVDs cause approximately 31% of deaths globally, and the numbers are increasing with the aging population and rising rates of hypertension, diabetes, and obesity. This, in turn, is causing the demand for stents used in the treatment of blockages in blood vessels to continue to increase.
Advancements in Stent Technology: Stent technology has significantly evolved, leading to improvements in patient outcomes. Drug-eluting stents (DES), for example, have revolutionized the field by releasing medication that prevents restenosis (the re-narrowing of arteries). Furthermore, bioabsorbable stents, which dissolve over time, are gaining popularity as they reduce the long-term risks associated with permanent implants.
Aging Population: The incidence of chronic diseases, such as cardiovascular diseases, increases with the rise in the global elderly population, thereby creating an urgent need for stent procedures. Stent placement is often necessary for the treatment of vascular diseases among these patients, hence driving the market for stents.
Growing Healthcare Infrastructure: The emerging markets, especially those in the Asia-Pacific region, are showing an increase in healthcare infrastructure. This growth, coupled with increasing government spending on healthcare, is helping to bring more access to stent procedures in developing countries as more people move into middle-class status and can afford medical treatments.
Rising Healthcare Awareness: Governments and medical organizations are investing in awareness campaigns to address cardiovascular diseases, resulting in more patients seeking stent treatment. As healthcare awareness rises, particularly in Asia-Pacific, the adoption of stents continues to grow rapidly.
Challenges Facing the Stent Market
Despite the growth, challenges still exist regarding the accessibility and affordability of stents:
High procedure and material cost: The stenting procedure costs—both the stent, imaging services, hospital stays, and post-procedure care—are high and hence not easily affordable in developing and lower-income countries. Although drug-eluting stents have proven very effective, their higher cost may continue to place them out of reach for many patients in countries where healthcare budgets are constrained.
Insurance Barriers: Due to insurance limitations, many patients, especially the elderly or those with chronic conditions, can hardly afford repeated stent implantation in a lifetime. Consequently, there is an obvious need for less expensive alternatives to ease the burden on patients and healthcare systems.
Key Players in the Stent Market
The stent market is characterized by intense competition, with several leading companies driving innovation and growth:
Abbott Laboratories : Being one of the biggest market players, Abbott offers a range of stent solutions, including drug-eluting and bioabsorbable stents.
Boston Scientific Corporation: Known for its advanced stent offerings, Boston Scientific leads in developing coronary and peripheral stents with cutting-edge technology.
Medtronic: One of the largest medical device companies, Medtronic offers a wide line of stent products used in vascular and non-vascular applications.
Cordis Corporation: Specializes in cardiovascular products, including stents for coronary and peripheral artery disease treatment.
B. Braun Melsungen: Besides a broad array of medical devices, B. Braun is also the producer of stents, driven by the idea to further its penetration in vascular and urological segments.
Terumo Corporation: A prominent name in the healthcare industry, Terumo offers innovative stent technologies catering to various vascular applications.
Biotronik: Known for its high-quality cardiovascular and neurovascular stents, Biotronik is recognized for its reliable product range in the global market.
Cook Medical: Specializing in peripheral stents, Cook Medical is making strides in the treatment of vascular diseases affecting the limbs and other organs.
Regional Insights
North America: Being the largest stent market, North America benefits from well-developed healthcare infrastructure, high health spending, and continuous technological advancement. The US will continue to be one of the major markets, owing to the presence of advanced medical technologies and a large patient population affected by cardiovascular diseases.
Asia-Pacific: The Asia-Pacific region is the fastest-growing market, driven by increased investment in healthcare, a rapidly aging population, and rising prevalence of cardiovascular diseases. Countries such as China, India, and Japan are undergoing rapid stent adoption due to better access to healthcare and increasing awareness about heart health.
Europe: Europe is considered a mature market with the presence of major players. Countries such as Germany, the UK, and France have well-established healthcare systems; however, the market is also being shaped by the growing demand for minimally invasive surgeries and the increasing use of bioabsorbable stents.
Latin America: Growing healthcare expenditure and adoption of modern medical technologies are driving the stent market in this region. Brazil and Mexico are the largest markets for stent adoption.
Middle East & Africa: This region is showing increased adoption of stents due to growing healthcare infrastructure and government investments in health services.
Outlook: The Future of the Stent Market
The stent market is expected to continue growing over the next decade, driven by advancement in technology, an aging global population, and increasing incidences of chronic diseases. Development of bioabsorbable and drug-eluting stents is expected to further revolutionize the treatment of patients and lower the chance of complications.
As access to healthcare continues to improve in emerging regions and as the awareness of cardiovascular health grows, there will be increased demand for stents; therefore, providing several opportunities for industry players to grow. The competitive landscape of this market will remain dynamic with Abbott Laboratories, Boston Scientific, Medtronic, and Cordis Corporation among others leading the trend.
Conclusion
the stent market is one of the major growth and innovation opportunities that can provide better patient outcomes, specifically in the regions where healthcare is advancing. With further technological development, increasing accessibility, and growing investments in healthcare, the stent market will soon become one of the integral parts of the solution for global healthcare.
To explore in-depth analysis in this report - Request Free Sample Report